the polarix trial: initial therapy of diffuse large b-cell lymphoma
Published 2 years ago • 3.8K plays • Length 4:47Download video MP4
Download video MP3
Similar videos
-
7:24
lymphoma: overview of classification
-
2:44
polarix study: frontline therapy in dlbcl
-
43:40
polatuzumab vedotin in previouslyuntreated diffuse large b-cell lymphoma.
-
0:59
polarix study design which led to the approval of polatuzumab #oncology #cancer #2023
-
3:12
polarix: polatuzumab vedotin and r-chp superior to r-chop in dlbcl
-
2:59
the polarix trial: polatuzumab with r-chp in dlbcl
-
1:20:47
practice-changing data in relapsed/refractory diffuse large b-cell lymphoma
-
2:00
polatuzumab vedotin and car t-cell therapy for diffuse large b-cell lymphoma
-
2:07
dr. hou on polatuzumab vedotin in dlbcl
-
24:45
what is the best initial therapy for peripheral t cell lymphoma?
-
27:06
peripheral t-cell lymphoma: what is new on the horizon?
-
53:43
8-4-2022 - cutaneous t cell lymphoma & life... & car-t therapy: engineering the immune system to...
-
0:47
neoprobe® in-service video: physician focus - binary mode for systemic injections
-
1:31
memosorb® :one and only fully bio-degradable occluder devices(english vesion)
-
32:08
international patient conference 2022 - basics of cutaneous lymphoma (in english)
-
1:42
precision medicine for b-cell lymphomas
-
6:35
mollecular and cellular biomedical technologies
-
0:55
new nanoparticle targets tumor-infiltrating immune cells, flips switch telling them to fight